English

Español

Pусский

Français

Deutsch

简体中文

Old Website
About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
Product Center
  • System
    • Nucleic Acid Extraction Solution
    • Real-time PCR System
  • Assay
    • Respiratory Infectious Diseases
    • Cervical Cancer Screening
    • Sexually Transmitted Diseases
    • Vector-Borne Diseases
    • Gastrointestinal Infectious Diseases
    • Zoonotic Infectious Diseases
    • Life Science
Media Center
  • News
  • Events
Service Network
  • Service Offering
  • e-Support
Careers
Contact Us
News Center
to grab latest progress of the company and industry
Bioperfectus is officially recognized as the valued membership of IFCC

BioPerfectus is pleased to announce that we now officially recognized as the valued membership of International Federation of Clinical Chemistry and Laboratory Medicine(IFCC).

2022-08-18 Read more
Your Problem, Our Solution

At Bioperfectus, the excellent experience of our customers is our goal and the key to our job. Last Wednesday, we completed online technical training for our distribution local support in the Asia Pacific region. The webinar covers insightful training on Bioperfectus Nucleic Acid Extraction System, Nucleic Acid Extraction Kit, Real-Time PCR System, and product demonstration on the newly launched SAW-96 Nucleic Acid Extraction Workstation.

2022-08-16 Read more
MHRA Registration Approval for BioPerfectus Monkeypox Virus Real Time PCR Kit

Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as “BioPerfectus”) is pleased to announce that Monkeypox Virus Real Time PCR Kit has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now officially available for Great Britain and Northern Ireland market.

2022-08-11 Read more
A Simplified HPV-DNA Workflow for Better Preventing Cervical Cancer

With over 600 thousand new cases and more than half that would lead to death each year, cervical cancer is listed as the fourth most frequent cancer among women worldwide.

2022-08-05 Read more
BioPerfectus Sexually Transmitted Disease Testing Solution

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections caused by organisms that can be transmitted from one person to another through sexual activity and intimate contact.

2022-07-29 Read more
Bioperfectus and ELITechGroup Announce Collaboration for Monkeypox Virus Testing across Europe

Bioperfectus is pleased to announce a strategic partnership with ELITechGroup S.p.A for monkeypox virus testing across Europe. The Monkeypox Virus Real Time PCR Kit from Bioperfectus in combination with the fully automated sample-to-result ELITe InGenius and BeGenius instruments from ELITechGroup will address the needs of major reference laboratories, hospitals, and disease control centers in Europe.

2022-07-21 Read more
Clinical Validation of Bioperfectus Monkeypox Virus Real Time PCR Kit in France

Bioperfectus, together with our partner in France, R-Biopharm France, has completed the clinical validation of the Bioperfectus Monkeypox Virus Real Time PCR Kit in l’institut de recherche biomédicale des armées (the Institute of Biomedical Research of the Armed Forces, IRBA), an organization established by the Army Health Service (SSA) in France.

2022-07-22 Read more
Publications included Bioperfectus Chlamydia Trachomatis Real Time PCR Kit

Chlamydia is a common STD (Sexually Transmitted Disease) that can cause infection among men and women, leading to permanent damage to women’s reproductive system, making it difficult or impossible to get pregnant later.

2022-07-18 Read more
BD SurePath is now officially validated for Bioperfectus HPV Real-Time PCR Kits!

Bioperfectus Human Papillomavirus Real Time PCR Kit & Human Papillomavirus Genotyping Real Time PCR Kit are free upgrading to meet different laboratories’ demands.

2022-07-13 Read more
HFMD Infection Diagnosis: The Release of Coxsackievirus A6 and A10 Real-Time PCR Kit

HFMD is a significant health and economic burden for the Asia Pacific region. It has been estimated that the average direct and indirect cost was US$129 for an outpatient, $484 for an inpatient, and $1936 for a severe case of HFMD, respectively.

2022-07-04 Read more
HomePrev12345678910...NextEnd
  • About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
  • Product Center
  • System
  • Assay
  • Media Center
  • News
  • Events
  • Service Network
  • Service Offering
  • e-Support
  • Careers
  • Contact Us
Follow Us

Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved. 苏ICP备14014835号-8

Tel: +86 021-5484 7326 Email: info@bioperfectus.com